4.7 Article

Metformin decreases angiogenesis via NF-κB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Thrombospondin-1 Deficiency Accelerates Atherosclerotic Plaque Maturation in ApoE-/- Mice

Rute Moura et al.

CIRCULATION RESEARCH (2008)

Article Endocrinology & Metabolism

The effect of metformin treatment on VEGF and PAI-1 Levels in obese type 2 diabetic patients

Canan Ersoy et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2008)

Article Biochemistry & Molecular Biology

Angiogenesis and inflammation in carotid atherosclerosis

Jerzy Krupinski et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2008)

Review Peripheral Vascular Disease

Thrombospondin-based antiangiogenic therapy

Xuefeng Zhang et al.

MICROVASCULAR RESEARCH (2007)

Article Endocrinology & Metabolism

Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome

F Gonzalez et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)

Article Cardiac & Cardiovascular Systems

BMK1/ERK5 is a novel regulator of angiogenesis by destabilizing hypoxia inducible factor 1α

XC Pi et al.

CIRCULATION RESEARCH (2005)

Article Endocrinology & Metabolism

Adipose tissue as an endocrine organ

EE Kershaw et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)

Article Biochemistry & Molecular Biology

Stimulation of PAI-1 and adipokines by glucose in human adipose tissue in vitro

G He et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)

Article Biochemistry & Molecular Biology

The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

L Devy et al.

FASEB JOURNAL (2002)